Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...
Affiliate content. See how LeanBliss and SuperThin stack up against each other when it comes to weight loss support.
26 (UPI) --The U.S. Food and Drug Administration has approved a new ... Health News // 19 hours ago Health plans at 1 in 5 large companies cover weight-loss drugs for employees Only a fifth ...
The U.S. Food and Drug Administration approved Pfizer's once-a-week injection for the two main types of a rare bleeding ...
The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...
The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...
Eli Lilly and Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, ...
The first new ... FDA's Center for Drug Evaluation and Research. "This drug takes the first new approach to schizophrenia treatment in decades," she said in an agency news release. "This approval ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...